Beam Therapeutics (BEAM) EBIT Margin (2019 - 2026)
Beam Therapeutics (BEAM) reported EBIT Margin of 337.81% for Q1 2026, up 125905.0% year-over-year from N/an in Q1 2025, and down 2109.66% on a QoQ basis from 15.29% in Q4 2025.
Beam Therapeutics (BEAM) has 8 years of EBIT Margin data on file, last reported at 337.81% in Q1 2026.
- Quarterly EBIT Margin rose 125905.0% year-over-year to 337.81% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 226.58% (up 45089.0% YoY) and the FY2025 annual result came in at 274.57%, up 37968.0% from the prior year.
- EBIT Margin declined to 337.81% in Q1 2026 per BEAM's latest filing, from 15.29% in the prior quarter.
- Across five years, EBIT Margin topped out at 42.02% in Q4 2023 and bottomed at 1596.87% in Q1 2025.
- The 5-year median for EBIT Margin is 577.9% (2022), against an average of 704.39%.
- The widest annual swing landed in 2022, when EBIT Margin soared 333864600 bps; it then tumbled 99663 bps in 2024.
- Tracing BEAM's EBIT Margin over 5 years: stood at 444.1% in 2022, then surged by 109 bps to 42.02% in 2023, then tumbled by 892 bps to 332.71% in 2024, then jumped by 95 bps to 15.29% in 2025, then tumbled by 2110 bps to 337.81% in 2026.
- Per Business Quant, the three latest BEAM EBIT Margin figures stand at 337.81% (Q1 2026), 15.29% (Q4 2025), and 1307.6% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 17.83% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 23.02% |
| 10 | Beam Therapeutics | 3.40 Bn | 3.40 Bn | - | -337.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -337.81% |
| Dec 31, 2025 | -15.29% |
| Sep 30, 2025 | -1,307.60% |
| Jun 30, 2025 | -1,419.22% |
| Mar 31, 2025 | -1,596.87% |
| Dec 31, 2024 | -332.71% |
| Sep 30, 2024 | -746.40% |
| Jun 30, 2024 | -891.06% |
| Mar 31, 2024 | -1,405.29% |
| Dec 31, 2023 | 42.02% |
| Sep 30, 2023 | -629.72% |
| Jun 30, 2023 | -507.79% |
| Mar 31, 2023 | -408.66% |
| Dec 31, 2022 | -444.10% |
| Sep 30, 2022 | -577.90% |
| Jun 30, 2022 | -492.23% |
| Mar 31, 2022 | -904.00% |
| Dec 31, 2021 | -124.31% |
| Sep 30, 2021 | -9,126.34% |
| Jun 30, 2021 | -982,900.00% |
| Mar 31, 2021 | -3,339,550.00% |
| Dec 31, 2020 | -679,983.33% |
| Sep 30, 2020 | -622,016.67% |
| Jun 30, 2020 | -438,083.33% |
| Mar 31, 2020 | -472,583.33% |
| Dec 31, 2019 | -439,516.67% |
| Sep 30, 2019 | -300,400.00% |
| Jun 30, 2019 | -294,183.33% |